OptiBiotix Health (GB:OPTI) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
OptiBiotix Health PLC has raised concerns over the validity of a recent share subscription by ProBiotix Health plc, which aimed to gather £1,226,400 for cardiometabolic health probiotic development. OptiBiotix claims that due to an error in the special resolution at ProBiotix’s annual general meeting, the subscription may be invalid, potentially impacting investors. The company plans to address this issue with AQUIS, the regulatory body for the AQSE Growth Market.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.